Home
Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. Market Share Analysis for May 2026

the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced the acceptance of four abstracts at the 2024 American Society of ...

Health > Biotechnology and Pharmaceuticals

Domainymabs.com

Year Founded2015

Employees51 - 200

Annual Revenue$50M - $75M

Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. (including company regionals)

ymabs.com

See more website traffic and engagement information

Y-mAbs Therapeutics, Inc. Revenue up to May 2026 is 50M - 75M

revenue generated by Y-mAbs Therapeutics, Inc. top domains

Y-mAbs Therapeutics, Inc. top domains revenue over 3 years

Revenue for Y-mAbs Therapeutics, Inc. top domains

ymabs.com50M - 75M

See more with Sales Intelligence

Total visits to Y-mAbs Therapeutics, Inc.'s top domains

Understand Y-mAbs Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ymabs.com4.5K

See more with Sales Intelligence

Avg. visit duration in Y-mAbs Therapeutics, Inc.'s top domains

Analyze Y-mAbs Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ymabs.com00:00:03

See more with Sales Intelligence

Avg. pageviews on Y-mAbs Therapeutics, Inc.'s top domains

See how Y-mAbs Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ymabs.com1.43

See more with Sales Intelligence

Y-mAbs Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Y-mAbs Therapeutics, Inc.

These are the website technologies, by industry, used by Y-mAbs Therapeutics, Inc. top domains

Widget (6)

Twemoji

Conversion & Analytics (3)

Google Analytics

Content Management System (2)

WordPress

Email Services (2)

Sendgrid

More Technologies

8

See all

News & Signals from Y-mAbs Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSERB Pharmaceuticals is planning to acquire Y-mAbs for $412M.SERB pharmaceuticals to acquire Y-mAbs therapeutics for $412 million.

NewsRossi left Y-mAbs as President and CEO on Jan 1st '26.Most recently, Rossi served as President and CEO of Y-mAbs Therapeutics, where he led the company's growth and successful acquisition by SERB Pharmaceuticals.

NewsSERB Pharmaceuticals acquired Y-mAbs for $412M on Sep 16th '25.West Conshohocken, PA, Sept. 16, 2025 (GLOBE NEWSWIRE) - SERB Pharmaceuticals ("SERB"), a global specialty pharmaceutical company focused on rare diseases and medical emergencies, today announced the successful completion of its acquisition of Y-mAbs Therapeutics, Inc. ("Y-mAbs"), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the treatment of cancer.